Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Science Advances · 2023
DOI: 10.1126/sciadv.adf3775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Yixiang Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, 435 East 30th Street, New York, N…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Synucleinopathies, Tauopathies. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Intracellular deposition of α-synuclein and tau are hallmarks of synucleinopathies and tauopathies, respectively. Recently, several dye-based imaging probes with selectivity for tau aggregates have been developed, but suitable imaging biomarkers for synucleinopathies are still unavailable. Detection of both of these aggregates early in the disease process may allow for prophylactic therapies before functional impairments have manifested, highlighting the importance of developing specific imaging probes for these lesions. In contrast to the β sheet dyes, single-domain antibodies, found in camelids and a few other species, are highly specific, and their small size allows better brain entry and distribution than whole antibodies. Here, we have developed such imaging ligands via phage display libraries derived from llamas immunized with α-synuclein and tau preparations, respectively. These probes allow noninvasive and specific in vivo imaging of α-synuclein versus tau pathology in mice, with the brain signal correlating strongly with lesion burden. These small antibody derivatives have great potential for in vivo diagnosis of these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, 435 East 30th Street, New York, NY 10016, USA.
- Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, 550 First Avenue, New York, NY 10016, USA.
- Department of Biochemistry and Molecular Biology, Michigan State University, 603 Wilson Road, East Lansing, MI 48824, USA.
- Department of Psychiatry, New York University Grossman School of Medicine, 435 East 30th Street, New York, NY 10016, USA.
ORCID-Profile: Yixiang Jiang, Yan Lin, Ruimin Pan, Einar M Sigurdsson
Förderung
- NCI NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- NIBIB NIH HHS
- NIH HHS
Zitieren
APA
Jiang, Y., Lin, Y., Krishnaswamy, S., Pan, R., Wu, Q., Sandusky-Beltran, L. A., Liu, M., Kuo, M. H., Kong, X. P., Congdon, E. E., & Sigurdsson, E. M. (2023). Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology. Science Advances. https://doi.org/10.1126/sciadv.adf3775
Vancouver
Jiang Y, Lin Y, Krishnaswamy S, Pan R, Wu Q, Sandusky-Beltran LA, et al. Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology. Science Advances. 2023. doi:10.1126/sciadv.adf3775
BibTeX
@article{Jiang2023,
author = {Jiang, Yixiang and Lin, Yan and Krishnaswamy, Senthilkumar and Pan, Ruimin and Wu, Qian and Sandusky-Beltran, Leslie A and Liu, Mengyu and Kuo, Min-Hao and Kong, Xiang-Peng and Congdon, Erin E and Sigurdsson, Einar M},
title = {Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adf3775}
}
EUVIMED